by Sue Robbins | Nov 14, 2019 | Migraine
Read more here.
by Sue Robbins | Nov 8, 2019 | Migraine
Eli Lilly, Allergan and Biohaven have a lot riding on their forthcoming migraine launches, and now cost-effectiveness watchdog ICER has come out with some less-than-stellar findings from data supporting the drugs. Read more...
by Sue Robbins | Nov 2, 2019 | Migraine
A significant proportion of children who present to headache clinics have joint hypermobility, according to data presented at the 48th national meeting of the Child Neurology Society. Furthermore, patients with joint hypermobility have a high rate of headache...
by Sue Robbins | Oct 30, 2019 | Migraine
In a newly published guide, federal health officials say doctors “should never abandon” pain patients and warn of acute withdrawal and other risks. Read more here.
by Sue Robbins | Oct 29, 2019 | Migraine
MIGRAINES ARE A VERY common and often debilitating, painful headache condition that affects some 39 million people in the United States, according to the Migraine Research Foundation. For those who experience them, the quest for relief can be lengthy. Read more...
by Sue Robbins | Oct 25, 2019 | Migraine
Fentanyl remains the deadliest drug in the United States. But in some areas of the country, methamphetamine kills more people. Read more here.
